Vir Biotechnology Inc
VIR·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$10.62
Today
-0.9%
YTD
+78.0%
About
Founded in 2016, Vir Biotechnology is a clinical-stage immunology company. It works to develop therapeutic products designed to treat and prevent a range of serious infectious diseases. Operating internationally, the company has headquarters in San Francisco, California. It is listed on the NASDAQ GS stock market with the VIR ticker. Add this stock to your eToro watchlist to follow VIR share price movements.
Price chart
Closing price history for VIR (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-3.18
P/S (TTM)22.41
P/B (TTM)1.98
Market cap$1.68B
Cap tierSmall-cap
Industry avg P/E-6.21
Profitability
Gross margin82.21%
EBIT margin-706.42%
Net margin-66.99%
ROE-47.69%
ROA-37.95%
Earnings & Revenue
Revenue (TTM)$65.50M
Revenue growth (1Y)+214.0%
EPS (TTM)-$3.14
Free cash flow$-449.64M
Total debt$95.58M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.63
Employees367
Next earnings4 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.